![Cameron Pitt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cameron Pitt
Fondateur chez Quanta Therapeutics, Inc.
Postes actifs de Cameron Pitt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Quanta Therapeutics, Inc.
![]() Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 01/01/2018 | - |
Fondateur | 01/01/2018 | - | |
Corporate Officer/Principal | 01/01/2018 | - |
Historique de carrière de Cameron Pitt
Anciens postes connus de Cameron Pitt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sofinnova Investments, Inc.
![]() Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Analyste en capital-investissement | 01/01/2018 | 30/04/2020 |
Formation de Cameron Pitt
University of California | Doctorate Degree |
Stanford University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Private Equity Analyst | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Sofinnova Investments, Inc.
![]() Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Quanta Therapeutics, Inc.
![]() Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Health Technology |
- Bourse
- Insiders
- Cameron Pitt
- Expérience